ABSTRACT
MT-IV, a newly discovered isomer, is expressed in tissues containing stratified squamous epithelial cells (11) but appears to be absent from the brain. The discovery of a MT-like protein in the brain (12), originally termed growth inhibitory factor (GIF) and later characterized as the brain-specific isomer , brought about the notion that MT-Ill may fulfill unique biological roles in brain homeostasis and perhaps also in pervasive neuropathology. Observalions that down-regulation of MT-Ill could lead to excessive neuritic sprouting and the formation of neurofibrillary tangles characteristic of Alzheimer's disease, reinforced by its apparent depletion in humans afflicted by the disease (12) and the increased sensitivity of MT-Ill "knockout" mice to kainic acid (KA) -induced seizures (14) , underlie the intense scientific pursuit for the potential role of MT-Ill in the etiology of neurodegenerative disorders. mate residues bestows acidic properties to MT-Ill, whereas the "conventional"
MT-I and MT-Il isoforms are of basic nature. Whereas the identity of X in the repeated Cys-X-Cys motifs of MT-I and MT-Il appears to be of little biochemical or physiological importance, the first of these motifs in MT-Ill contains proline (Pro), with the following sequence:
-Cys-Pro-Cys-Pro-. The presence of the Pro residues in the peptide backbone/side chains of noncysteine amino acid residues, along with the Thr residue in the amino-terminal sequence of MT-Ill, and its acidic properties and charged surface are likely to endow the molecule with the receptor recognition sites necessary for its biological activity, such as its brain growth inhibitory function (12, 15) . The growth inhibitory activity of MT-Ill (but not MT-I and MT-Il) on the survival of rat neurons cultured in extracts of Alzheimer-diseased brains is dependent on the amino-terminal n-domain of MT-Ill, and the two prolines at positions 7 and 9 of the peptide backbone are essential for this activity (14) .
MT synthesis is controlled by the process of transcription initiation where a variety of cis-and trans-acting elements are involved (2-5, 10, 16, 17 Little is known also about the mechanisms controlling the degradation of MT from tissues, although it is widely speculated that such processes occur in the lysosomes.
REGIONAL AND CELL-SPECIFIC DISTRIBUTION OF BRAIN METALLOTHIONEINS
Analysis of the regional distribution of MTs suggests that in general the relative abundance of MT mRNAs for all brain isoforms is quite identical, with all three isoforms being constitutively expressed throughout the CNS. MT-I and MT-Ill mRNA accumulate in the brain with similar, but not identical, kinetics during development, and both are expressed concurrently in the olfactory bulb, cortex, hippocampus, brainstem, and spinal cord (14, 24) . Each isoform accounts for approximately 0.2% of total brain mRNA. The distribution of MT-Il mRNA is assumed to mimic the distribution of MT-I mRNA because their genes are coordinately expressed and respond in parallel to a variety of inducers (25). The relative abundance of brain MT mRNA is as follows:
MT-I>MT-III> MT-Il (24). MT mRNA for all MT isoforms is particularly abundant in the olfactory bulb, and lowest in the eye (24). MT-I and MT-IL transcripts are also abundant in the cerebellum, a region expressing conspicuously low levels of . MT-Ill mRNA is predominantly expressed in regions with high concentrations of vesicular zinc such as the hippocatnpus, piriform cortex, and the amygdala (13, 23, 26) .
The cellular localization of MTs in the mammalian brain has been the subject of numerous studies (24, (26) (27) (28) (29) .
Collectively, these studies point to differences in MT-Ill vs. MT-I and MT-Il transcript distribution and protein levels. The brain-specific MT-Ill isoform appears to be largely absent from white matter enriched with glial cells, whereas MT-I and MT-Il isoforms are prevalent within these same areas. In addition,
MT-I appears conspicuously absent from well-defined neuronal populations of the hippocampus and dentate gyrus, but abundant in fibrous portions of these structures that are populated with glial cell bodies. An exception to the generalization that MT-I and MT-Il are associated predominantly with glial cells are the neurons in the CA3 portion of the hippocampus (26), which appear to simultaneously express (at least in the rat) both MT-I and MT-Ill isoforms (and presumably MT-Il 
MT-Il! and Zn horneostasis in the hippocampus
MT-Ill mRNA is widely expressed in the adult brain and is particularly abundant in regions with high concentrations of "vesicular zinc" such as hippocampus (26, 61).
13-Galactosidase activity in transgenic mice, where 11.5 kb of the mouse MT-Ill 5' flanking region was fused to nlacZ, points to an excellent correlation between neuronal cell bodies that give the most intense hybridization signal for MT-Ill mRNA and those containing Zn, as verified by means of selenide-staining (14, 26) . Transgenic mice with a cosmid containing the human MT-Ill gene and 20 kb of 5' flanking region express high levels of MT-Ill mRNA and protein as well as zinc, but not other metals, paralleling the endogenous distribution of both the protein and zinc (26, 61). Thus, in addition to the conventional functions attributed to MT, namely, storage and transport of metals within neurons and/or synaptic vesicles, protection from tnetal toxicity and oxidative stress, the cell-specific distribution of MT-Ill supports the idea that MT-Ill may have added functions distinct from those of MT-I and MT-Il isoforms. Consistent with this hypothesis are recent observations that the gene encoding for MT-Ill responds poorly, or not at all, to stimuli that induce MT-I and MT-Il (such as KA; 50) and that MT-Ill-expressing cells respond to zinc deficiency differently than do MT-I-expressing cells (62). It has been suggested that MT-Ill serves as a neuromodulator (13, 63) . Zinc is released at glutamatergic synapses in response to depolarization and possesses characteristics of a neuromodulator for the ionotropic glutamate receptors (62). Neuronal response patterns to zinc are largely dependent on the receptor subtype. NMDA receptor-induced ion channel activities are inhibited by zinc. Low concentrations of zinc potentiate the activity of amino-3-hydroxy-5-methylisoxazol-4-propionic acid (AMPA) and KA receptors, whereas at concentrations exceeding 100 .tM, zinc inhibits both AMPA and KA receptors (63). In addition, zinc blocks 'y-aminobutyric acid (GABA) -gated ion currents at the GABAA receptors.
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